Thu, Sep 29, 2016
Pharma major Lupin on Thursday said it has received final approval from the US health regulator to market its memantine hydrochloride extended-release capsules, which are used in the treatment of the Alzheimer's disease.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
